NYSE:TOVX | EBITDA | Theriva Biologics, Inc.

Complete source-backed ebitda history.

Available history
2013-12-31 to 2026-03-31
Data captured

Historical EBITDA

DateEBITDA
2026-03-31-$2.1M
2025-12-31-$2.04M
2025-03-31-$4.39M
2024-12-31-$4.55M
2024-03-31-$5.35M
2023-12-31-$6.18M
2023-03-31-$5.15M
2022-12-31-$7.29M
2022-03-31-$4.23M
2021-12-31-$5.25M
2021-03-31-$2.5M
2020-12-31-$2.1M
2020-03-31-$2.97M
2019-12-31-$3.15M
2019-03-31-$3.51M
2018-12-31-$3.19M
2018-03-31-$4.92M
2017-12-31-$5.71M
2017-03-31-$8.09M
2016-12-31-$10.16M
2016-03-31-$10.54M

Annual EBITDA

DateEBITDA
2025-12-31-$23.94M
2024-12-31-$26.21M
2023-12-31-$21.3M
2022-12-31-$21.5M
2021-12-31-$14.19M
2020-12-31-$9.96M
2019-12-31-$15.42M
2018-12-31-$17.3M
2017-12-31-$26.01M
2016-12-31-$39.1M
2015-12-31-$40.91M
2014-12-31-$20.48M
2013-12-31-$12.3M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.